STI-571: an anticancer protein-tyrosine kinase inhibitor
- 29 August 2003
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 309 (4) , 709-717
- https://doi.org/10.1016/j.bbrc.2003.08.055
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinibBlood, 2003
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- The origins of protein phosphorylationNature Cell Biology, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- The Hallmarks of CancerCell, 2000
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- MOLMOL: A program for display and analysis of macromolecular structuresJournal of Molecular Graphics, 1996
- Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosineNature, 1980